Showing results (131-140 of 150) with videos related to
Sort By:
Pageof 15
Circulation|March 1, 1984
Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technologyF Van de Werf, S R Bergmann, K A Fox, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1989
Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarctionM N Walsh, E M Geltman, M A Brown, et al.The American Journal of Cardiology|December 1, 1996
Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarctionP J Rubin, D S Lee, V G Dávila-Román, et al.Circulation|September 1, 1988
Delineation of impaired regional myocardial perfusion by positron emission tomography with H2(15)OM N Walsh, S R Bergmann, R L Steele, et al.The American Journal of Medicine|October 1, 1982
Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomographyS R Bergmann, R A Lerch, K A Fox, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1988
Detection of rejection of canine orthotopic cardiac allografts with indium-111 lymphocytes and gamma scintigraphyH J Eisen, M Rosenbloom, J C Laschinger, et al.Circulation|April 1, 1991
Induction of sustained patency after clot-selective coronary thrombolysis with Hybrid-B, a genetically engineered plasminogen activator with a prolonged biological half-lifeC J Weinheimer, H L James, N K Kalyan, et al.Journal of the American College of Cardiology|September 1, 1992
Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolismR J Gropler, E M Geltman, K Sampathkumaran, et al.Journal of the American College of Cardiology|November 15, 1993
Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomographyR J Gropler, E M Geltman, K Sampathkumaran, et al.The New England Journal of Medicine|March 8, 1984
Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarctionF Van de Werf, P A Ludbrook, S R Bergmann, et al.Pageof 15